Action AGUAS DA CURIA - CUR

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

1,17

Prix Achat

1,17

Prix Vente

1,17

Volume échangé

0,00

0,00 Fourchette du Jour 0,00

1,17 Plage de 52 semaines 1,17

Clôture Veille

1,17

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

0,00

Volume financier

VWAP

Neuralstem Completes $5.25 Million Financing

Received NYSE AMEX Notice of Compliance ROCKVILLE, Md., Feb. 18 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE AMEX: CUR) announced today that...

Neuralstem Announces First Patient Treated in ALS Stem Cell Trial

ROCKVILLE, Md., Jan. 21 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that the first ALS patient was treated with its...

Neuralstem Receives Approval To Commence First ALS Stem Cell Trial at Emory ALS Center

ROCKVILLE, Md., Dec. 18 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Amex: CUR) today announced that its Phase I trial to treat Amyotrophic...

Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update

ROCKVILLE, Md., Nov. 17 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Amex: CUR) today provided a financial and business update for the third...

Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial

ROCKVILLE, Md., Sept. 21 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Amex: CUR) today announced that the U.S. Food and Drug Administration...

Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Neuralstem, Inc.

NEW YORK, April 6 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R...

Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS

Make Synaptic Contact with Host Motor Neurons ROCKVILLE, Md., March 9 /PRNewswire-FirstCall/ -- Transplanted human neural stem cells (hNSCs...

Neuralstem's ALS Trial on Clinical Hold

ROCKVILLE, Md., Feb. 20 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Alternext US: CUR) announced today its spinal cord stem cell trial to...

Senator James Sasser, Former Ambassador to China, Joins Neuralstem Advisory Board

ROCKVILLE, Md., Feb. 12 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Alternext US: CUR) announced today that James Sasser, former Senator...

Neuralstem to Present at the 11th Annual BIO CEO & Investor Conference

ROCKVILLE, Md., Feb. 2 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Alternext US: CUR) announced today that Richard Garr, CEO and President...

Période	Ouver.	Haut	Bas
1	1.17	1.17	1.17	DE
4	1.17	1.17	1.17	DE
12	1.17	1.17	1.17	DE
26	1.17	1.17	1.17	DE
52	1.17	1.17	1.17	DE
156	1.17	1.17	1.17	DE
260	1.17	1.17	1.17	DE

CUR - Frequently Asked Questions (FAQ)

What is the current AGUAS DA CURIA share price?

The current share price of AGUAS DA CURIA is 1,17 €

What is the 1 year trading range for AGUAS DA CURIA share price?

AGUAS DA CURIA has traded in the range of 1,17 € to 1,17 € during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
ABCAABC Arbitrage	5,27 € (0,00%)	0
ABAb Science	1,546 € (0,00%)	0
AALBAalberts NV	34,78 € (0,00%)	0
AAAAlan Allman Associates	4,78 € (0,00%)	0
74SW74Software SA	27,50 € (0,00%)	0
ABCAABC Arbitrage	5,27 € (0,00%)	0
ABAb Science	1,546 € (0,00%)	0
AALBAalberts NV	34,78 € (0,00%)	0
AAAAlan Allman Associates	4,78 € (0,00%)	0
74SW74Software SA	27,50 € (0,00%)	0
ABCAABC Arbitrage	5,27 € (0,00%)	0
ABAb Science	1,546 € (0,00%)	0
AALBAalberts NV	34,78 € (0,00%)	0
AAAAlan Allman Associates	4,78 € (0,00%)	0
74SW74Software SA	27,50 € (0,00%)	0

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

AGUAS DA CURIA (CUR)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

CUR Dernières nouvelles

Neuralstem Completes $5.25 Million Financing

Neuralstem Announces First Patient Treated in ALS Stem Cell Trial

Neuralstem Receives Approval To Commence First ALS Stem Cell Trial at Emory ALS Center

Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update

Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial

Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Neuralstem, Inc.

Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS

Neuralstem's ALS Trial on Clinical Hold

Senator James Sasser, Former Ambassador to China, Joins Neuralstem Advisory Board

Neuralstem to Present at the 11th Annual BIO CEO & Investor Conference

CUR - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

AGUAS DA CURIA (CUR) Cours

AGUAS DA CURIA (CUR)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

CUR Dernières nouvelles

Neuralstem Completes $5.25 Million Financing

Neuralstem Announces First Patient Treated in ALS Stem Cell Trial

Neuralstem Receives Approval To Commence First ALS Stem Cell Trial at Emory ALS Center

Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update

Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial

Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Neuralstem, Inc.

Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS

Neuralstem's ALS Trial on Clinical Hold

Senator James Sasser, Former Ambassador to China, Joins Neuralstem Advisory Board

Neuralstem to Present at the 11th Annual BIO CEO & Investor Conference

CUR - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités